Intra Cellular Therapies | Beban Penjualan Dan Administrasi

Selling And Administration Expenses Perubahan Tanggal
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
ALKERMES USD 167.95M 37.31M 2023-09
Cytokinetics USD 44.11M 4M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
Intra Cellular Therapies USD 104.72M 487K 2023-12
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
RedHill Biopharma USD 8.06M 2.85M 2023-06
Supernus Pharmaceuticals USD 81.28M 1.42M 2023-12
United Therapeutics USD 128.6M 1000K 2023-12



Intra Cellular Therapies Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Apr 2024.